MSB 2.03% $1.45 mesoblast limited

Ann: First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS, page-8

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 19,371 Posts.
    lightbulb Created with Sketch. 6494
    This trial is never going to finish recruitment as it will be stopped early. I will be impressed if we get to the end of May and the data safety and monitoring committee hasn't already stopped the trial for overwhelming efficiency.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.